BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Dagan Lonsdale//NONSGML Clinical pharmacology year 1 calendar//EN
CALSCALE:GREGORIAN
BEGIN:VEVENT
UID:64b42a6a-b157-469f-838b-47458016783b
DTSTAMP:20250702T140227
DTSTART:19551009T140000
DTEND:19551009T150000
SUMMARY:PK Introduction to pharmacokinetics
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:Curve LT
END:VEVENT
BEGIN:VEVENT
UID:84c4f17c-0ad4-43c6-ae71-ea902d5eef6e
DTSTAMP:20250702T140227
DTSTART:19551015T100000
DTEND:19551015T110000
SUMMARY:PK 1.1 Drug formulation
DESCRIPTION:Module: PHA403, Person delivering: Dagan/ Toqa
LOCATION:Curve LT
END:VEVENT
BEGIN:VEVENT
UID:576b6b79-e8da-462c-a748-444006e05515
DTSTAMP:20250702T140227
DTSTART:19551023T110000
DTEND:19551023T120000
SUMMARY:PK 1.2 Enteral administration
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:Curve LT
END:VEVENT
BEGIN:VEVENT
UID:b1dafb0d-c8bf-48c7-aeb0-da6e08f68e2a
DTSTAMP:20250702T140227
DTSTART:19551023T120000
DTEND:19551023T130000
SUMMARY:PK 1.3 Parenteral administration
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:Curve LT
END:VEVENT
BEGIN:VEVENT
UID:577e0bba-16a9-4d15-8c92-402662a35eb8
DTSTAMP:20250702T140227
DTSTART:19551029T150000
DTEND:19551029T160000
SUMMARY:PK 1.4 Drug absorption
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:LTF
END:VEVENT
BEGIN:VEVENT
UID:2bf9da4b-4533-485d-b98b-21a411c3327f
DTSTAMP:20250702T140227
DTSTART:19551103T140000
DTEND:19551103T150000
SUMMARY:PK 1.6 Drug distribution
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:8f4c0f06-5bc0-4c7f-a530-f85c7fa3e7a8
DTSTAMP:20250702T140227
DTSTART:19551103T150000
DTEND:19551103T160000
SUMMARY:PK 1.6 Drug distribution
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:5e85f315-031c-45b7-947b-904655e62738
DTSTAMP:20250702T140227
DTSTART:19551110T130000
DTEND:19551110T140000
SUMMARY:PK 1.8 Volume of distribution
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:a101eecd-8d40-4e61-8f98-f4e3e826def5
DTSTAMP:20250702T140227
DTSTART:19551110T140000
DTEND:19551110T150000
SUMMARY:PK Volume of distribution - introduction to calculations
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:78faea3b-fa8b-4d87-ac04-b889f1fb1b5f
DTSTAMP:20250702T140227
DTSTART:19551113T100000
DTEND:19551113T110000
SUMMARY:PK Introduction to visualising pharmacokinetic data using R
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:H5.1, H5.2 computing and H5.3 teaching
END:VEVENT
BEGIN:VEVENT
UID:79c50c29-49d9-48c1-8b0a-5a58df3ef3f3
DTSTAMP:20250702T140227
DTSTART:19551113T110000
DTEND:19551113T120000
SUMMARY:PK Introduction to visualising pharmacokinetic data using R
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:H5.1, H5.2 computing and H5.3 teaching
END:VEVENT
BEGIN:VEVENT
UID:7442f06c-d30f-4fff-b75f-c4984ee24282
DTSTAMP:20250702T140227
DTSTART:19551119T120000
DTEND:19551119T130000
SUMMARY:PK 1.7 Drug metabolism by the liver 1
DESCRIPTION:Module: PHA403, Person delivering: Mark
LOCATION:LTF
END:VEVENT
BEGIN:VEVENT
UID:3aedcfc4-b04d-4d9e-9315-ab625635072d
DTSTAMP:20250702T140227
DTSTART:19551126T110000
DTEND:19551126T120000
SUMMARY:PK 1.9 Drug excretion including renal elimination
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:LTG
END:VEVENT
BEGIN:VEVENT
UID:858f25d9-afc4-4a27-a1f8-1548c5e87016
DTSTAMP:20250702T140227
DTSTART:19551126T120000
DTEND:19551126T130000
SUMMARY:PK 1.10 Drug clearance
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:LTG
END:VEVENT
BEGIN:VEVENT
UID:bc7be7f6-b7b7-4f6c-be38-598f3033e7fe
DTSTAMP:20250702T140227
DTSTART:19551126T140000
DTEND:19551126T150000
SUMMARY:PK Joint workshop with fundamentals of science
DESCRIPTION:Module: PHA403, Person delivering: Dagan, Toqa, Jen
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:08367b20-a241-4761-8f49-eb6c678c7960
DTSTAMP:20250702T140227
DTSTART:19551127T140000
DTEND:19551127T150000
SUMMARY:PK Recap and review
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:6965bb13-91ce-4b3f-b3c9-7eaebc1192cf
DTSTAMP:20250702T140227
DTSTART:19551127T150000
DTEND:19551127T160000
SUMMARY:PK Recap and review
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:9fe69dc6-3c0b-4855-b123-dec3fc703b82
DTSTAMP:20250702T140227
DTSTART:19560104T140000
DTEND:19560104T150000
SUMMARY:PK Bioanalytical techniques
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:fab2379e-fd26-4944-b9e0-813250c6f87c
DTSTAMP:20250702T140227
DTSTART:19560104T150000
DTEND:19560104T160000
SUMMARY:PK Bioanalytical techniques
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:5793512a-5cdf-4a6b-a3b8-9ea68c857b4f
DTSTAMP:20250702T140227
DTSTART:19560114T150000
DTEND:19560114T160000
SUMMARY:PK 1.12 Therapeutic drug monitoring
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:Curve LT
END:VEVENT
BEGIN:VEVENT
UID:64db1ab5-cb48-4c66-95ca-6c214a32cc53
DTSTAMP:20250702T140227
DTSTART:19560202T100000
DTEND:19560202T110000
SUMMARY:PK 2.1 Non-compartmental analysis 
Group 1 90 mins
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:H1.8 and H1.9
END:VEVENT
BEGIN:VEVENT
UID:57245a03-dd5e-4f99-91b3-a8a4da9b403d
DTSTAMP:20250702T140227
DTSTART:19560202T110000
DTEND:19560202T120000
SUMMARY:PK 2.1 Non-compartmental analysis
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:H1.8 and H1.9
END:VEVENT
BEGIN:VEVENT
UID:fa6d0370-a9bd-4292-973b-381ae8e3cb83
DTSTAMP:20250702T140227
DTSTART:19560202T120000
DTEND:19560202T130000
SUMMARY:PK 2.1 Non-compartmental analysis 
Group 2 90 mins
DESCRIPTION:Module: PHA403, Person delivering: Dagan
LOCATION:H1.8 and H1.9
END:VEVENT
BEGIN:VEVENT
UID:d29673b2-785f-4c15-a669-4716271bbb78
DTSTAMP:20250702T140227
DTSTART:19560211T120000
DTEND:19560211T130000
SUMMARY:PK 2.2 Introduction to PK of biologics
DESCRIPTION:Module: PHA403, Person delivering: Reya
LOCATION:Curve LT
END:VEVENT
BEGIN:VEVENT
UID:d8079b78-93c4-4439-a372-c40ccdab35b0
DTSTAMP:20250702T140227
DTSTART:19560225T110000
DTEND:19560225T120000
SUMMARY:PK 2.3 Renal disease and drug handling workshop
DESCRIPTION:Module: PHA403, Person delivering: Mark
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:42c09985-4df4-427a-9ebc-4d14b5f64584
DTSTAMP:20250702T140227
DTSTART:19560225T120000
DTEND:19560225T130000
SUMMARY:PK 2.3 Renal disease and drug handling workshop
DESCRIPTION:Module: PHA403, Person delivering: Mark
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:42399a6a-a6c6-474a-8cff-75d7efe29237
DTSTAMP:20250702T140227
DTSTART:19560315T110000
DTEND:19560315T120000
SUMMARY:PK 2.4 Liver disease and drug handling
DESCRIPTION:Module: PHA403, Person delivering: Cleodie
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:0519d987-5dd1-4d9d-8c38-eb009dd52b6f
DTSTAMP:20250702T140227
DTSTART:19560315T120000
DTEND:19560315T130000
SUMMARY:PK 2.4 Liver disease and drug handling
DESCRIPTION:Module: PHA403, Person delivering: Cleodie
LOCATION:
END:VEVENT
BEGIN:VEVENT
UID:c65c357f-9530-4911-8ccc-25ca130251f3
DTSTAMP:20250702T140227
DTSTART:19560513T120000
DTEND:19560513T130000
SUMMARY:PK 2.5 Bioequivalence 1
DESCRIPTION:Module: PHA403, Person delivering: Toqa
LOCATION:Lecture theatre F
END:VEVENT
BEGIN:VEVENT
UID:8423017d-d187-463f-9b66-d5e31f281b6b
DTSTAMP:20250702T140227
DTSTART:19560527T100000
DTEND:19560527T110000
SUMMARY:PK revision
DESCRIPTION:Module: PHA403, Person delivering: Toqa, Dagan
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:af6f2fac-6f32-4c92-961c-079dfe4b3b47
DTSTAMP:20250702T140227
DTSTART:19560527T110000
DTEND:19560527T120000
SUMMARY:PK revision
DESCRIPTION:Module: PHA403, Person delivering: Toqa, Dagan
LOCATION:J0.7
END:VEVENT
BEGIN:VEVENT
UID:8623f10f-49b7-4bf9-a4f4-89bc584a51fc
DTSTAMP:20250702T140227
DTSTART:19560527T120000
DTEND:19560527T130000
SUMMARY:PK revision
DESCRIPTION:Module: PHA403, Person delivering: Toqa, Dagan
LOCATION:J0.7
END:VEVENT
END:VCALENDAR
